DOCK7 Gene Early infantile epileptic encephalopathy type 23 Genetic Test sale cost 4400 AED
SPR Gene Dystonia DOPA-Responsive Autosomal Recessive Genetic Test sale cost 4400 AED SPR Gene Dystonia DOPA-Responsive Autosomal Recessive Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
GUF1 Gene Early infantile epileptic encephalopathy type 40 Genetic Test sale cost 4400 AED GUF1 Gene Early infantile epileptic encephalopathy type 40 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

DOCK7 Gene Early infantile epileptic encephalopathy type 23 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The DOCK7 gene is associated with early infantile epileptic encephalopathy type 23 (EIEE23), a severe neurological disorder that typically manifests in the early stages of infancy. This condition is characterized by frequent seizures that are resistant to treatment, along with developmental delays and other potential neurological issues. The DOCK7 gene plays a crucial role in brain development and function, and mutations in this gene can disrupt normal neurological processes, leading to the symptoms observed in EIEE23.

To diagnose this condition accurately, genetic testing for mutations in the DOCK7 gene is essential. DNA Labs UAE offers a comprehensive genetic test specifically designed to identify mutations in the DOCK7 gene that are associated with early infantile epileptic encephalopathy type 23. This test is a critical tool for clinicians in diagnosing the condition, allowing for a better understanding of the prognosis and informing treatment strategies.

The cost of the DOCK7 gene test at DNA Labs UAE is 4400 AED. This investment includes the collection of a DNA sample, usually through a blood draw or cheek swab, and the subsequent analysis of the DOCK7 gene for any mutations. The results from this test can provide invaluable insights for families and healthcare providers, guiding them towards appropriate care and support for affected individuals.

Overall, the DOCK7 gene test offered by DNA Labs UAE is a specialized diagnostic tool that plays a pivotal role in identifying early infantile epileptic encephalopathy type 23, facilitating early intervention and tailored management plans for patients with this challenging condition.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

DOCK7 Gene Early Infantile Epileptic Encephalopathy Type 23 Genetic Test

At DNA Labs UAE, we offer the DOCK7 Gene Early Infantile Epileptic Encephalopathy Type 23 Genetic Test for individuals who are experiencing symptoms of this rare genetic disorder. The test is designed to identify mutations in the DOCK7 gene that may be responsible for Early Infantile Epileptic Encephalopathy Type 23 (EIEE23), which is characterized by seizures and developmental delays in infants.

Test Components and Price

The DOCK7 Gene Early Infantile Epileptic Encephalopathy Type 23 Genetic Test is priced at 4400.0 AED. The test requires a blood sample or extracted DNA, or one drop of blood on an FTA card.

Report Delivery and Method

After the sample is collected, the report will be delivered within 3 to 4 weeks. The test utilizes NGS (Next-Generation Sequencing) technology for accurate and reliable results.

Test Type and Doctor

The DOCK7 Gene Early Infantile Epileptic Encephalopathy Type 23 Genetic Test falls under the category of Neurological Disorders. It is recommended to consult with a Neurologist for this test.

Test Department and Pre Test Information

The test is conducted in our Genetics department. Before undergoing the DOCK7 Gene Early Infantile Epileptic Encephalopathy Type 23 Genetic Test, it is important to provide the clinical history of the patient. Additionally, a Genetic Counselling session will be conducted to draw a pedigree chart of family members affected by EIEE23.

About EIEE23 and the Importance of Genetic Testing

EIEE23 is a rare genetic disorder that affects infants, causing seizures and developmental delays. By undergoing the DOCK7 Gene Early Infantile Epileptic Encephalopathy Type 23 Genetic Test, mutations in the DOCK7 gene can be identified, aiding in the diagnosis of the disorder. This test also provides valuable information about the risk of passing on the disorder to future generations. Additionally, the test results can guide treatment decisions and help families access the necessary support and resources.

Test Name DOCK7 Gene Early infantile epileptic encephalopathy type 23 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for DOCK7 Gene Early infantile epileptic encephalopathy type 23 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with DOCK7 Gene Early infantile epileptic encephalopathy type 23
Test Details

The DOCK7 gene is associated with Early Infantile Epileptic Encephalopathy Type 23 (EIEE23), a rare genetic disorder that causes seizures and developmental delays in infants. NGS genetic testing can be used to identify mutations in the DOCK7 gene that may be responsible for EIEE23. This type of genetic testing can help diagnose the disorder and provide information about the risk of passing it on to future generations. It can also guide treatment decisions and help families access support and resources.

SKU: TEST-1289 Category:

Related products